Gestational Trophoblastic Tumors and Related Tumorlike Lesions

  • Ie-Ming ShihEmail author
  • Brigitte M. Ronnett
  • Michael Mazur
  • Robert J. Kurman
Living reference work entry


Gestational trophoblastic disease (GTD) encompasses a heterogeneous group of lesions with specific clinical features, morphological characteristics, and pathogenesis. The World Health Organization classification of GTD includes complete and partial hydatidiform mole, invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT), epithelioid trophoblastic tumor, exaggerated placental site, and placental site nodule (Table 1). Some of these lesions are true neoplasms, whereas others represent abnormally formed placentas with a predisposition for neoplastic transformation of the trophoblast. Two benign entities, the exaggerated placental site and the placental site nodule, are included because they are trophoblastic lesions that must be distinguished from other entities with malignant potential. The literature on GTD is extensive and at times confusing because of inconsistencies in classification and terminology. In fact, the necessity of a morphologic classification has been questioned, because current management is largely medical and in the case of trophoblastic disease following a mole, treatment is often conducted in the absence of a histological diagnosis. Thus, all trophoblastic lesions are frequently combined under the rubric of GTD without applying specific pathological terms. However, studies have demonstrated profound differences in the etiology, morphology, and clinical behavior of various forms of the disease. These studies underscore the importance of a uniform histological classification to facilitate standardized reporting of data and to ensure appropriate clinical management. Nonetheless, the term “GTD” has clinical utility, as the principles of human chorionic gonadotropin (hCG) monitoring in follow-up and the chemotherapy of metastatic or persistent disease are similar for all these entities.


  1. Altieri A et al (2003) Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 4(11):670–678PubMedCrossRefPubMedCentralGoogle Scholar
  2. Aranake-Chrisinger J et al (2016) Use of short tandem repeat analysis in unusual presentations of trophoblastic tumors and their mimics. Hum Pathol 52:92–100PubMedCrossRefPubMedCentralGoogle Scholar
  3. Arroyo MR et al (2008) Placental site trophoblastic tumor in the ovary of a young child with isosexual precocious puberty. Pediatr Dev Pathol 12:73–76CrossRefGoogle Scholar
  4. Baergen RN, Rutgers J, Young RH (2003) Extrauterine lesions of intermediate trophoblast. Int J Gynecol Pathol 22(4):362–367PubMedCrossRefPubMedCentralGoogle Scholar
  5. Baergen RN et al (2006) Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol 100(3):511–520PubMedCrossRefPubMedCentralGoogle Scholar
  6. Bagshawe KD et al (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335(8697):1074–1076PubMedCrossRefPubMedCentralGoogle Scholar
  7. Banet N et al (2013) Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol 27:238PubMedCrossRefPubMedCentralGoogle Scholar
  8. Banet N et al (2015) GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility. Am J Surg Pathol 39(1):101–108PubMedPubMedCentralCrossRefGoogle Scholar
  9. Berkowitz LW, Lage JM (1990) Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol 36:358–362PubMedCrossRefPubMedCentralGoogle Scholar
  10. Berkowitz RS et al (1998) Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 43(1):81–86PubMedPubMedCentralGoogle Scholar
  11. Bifulco C et al (2008) Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 32(3):445–451PubMedCrossRefPubMedCentralGoogle Scholar
  12. Brown J et al (2017) 15years of progress in gestational trophoblastic disease: scoring, standardization, and salvage. Gynecol Oncol 144(1):200–207PubMedCrossRefPubMedCentralGoogle Scholar
  13. Burrows TD, King A, Loke YW (1994) Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta 15(1):21–33PubMedCrossRefPubMedCentralGoogle Scholar
  14. Carinelli SG, Verdola N, Zanotti F (1989) Placental site nodule: a report of 17 cases. Pathol Res Pract 185:30–34Google Scholar
  15. Castrillon DH et al (2001) Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol 25(10):1225–1230PubMedCrossRefPubMedCentralGoogle Scholar
  16. Chang YL et al (1999) Prognostic factors and treatment for placental site trophoblastic tumor- report of 3 cases and analysis of 88 cases. Gynecol Oncol 73(2):216–222PubMedCrossRefPubMedCentralGoogle Scholar
  17. Cheung AN et al (1998) p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol 51(2):159–162PubMedPubMedCentralCrossRefGoogle Scholar
  18. Chew SH et al (2000) Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol 31(8):914–924PubMedCrossRefPubMedCentralGoogle Scholar
  19. Chilosi M et al (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Investig 78(3):269–276PubMedPubMedCentralGoogle Scholar
  20. Cole LA (2009) New discoveries on the biology and detection of human chorionic gonadotropin. Reprod Biol Endocrinol 7(1):8PubMedPubMedCentralCrossRefGoogle Scholar
  21. Cole LA et al (2006) Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 102(2):160–164PubMedCrossRefGoogle Scholar
  22. Cole KA et al (2008a) A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6(5):735–742PubMedPubMedCentralCrossRefGoogle Scholar
  23. Cole ME et al (2008b) Placental-site trophoblastic tumors: a case of resistant pulmonary metastasis. Nat Clin Pract Oncol 5(3):171–175PubMedCrossRefGoogle Scholar
  24. Coukos G et al (1999) Complete hydatidiform mole. A disease with a changing profile [In process citation]. J Reprod Med 44(8):698–704PubMedGoogle Scholar
  25. Czernobilsky B, Barash A, Lancet M (1982) Partial moles: a clinicopathologic study of 25 cases. Obstet Gynecol 59:75–77PubMedGoogle Scholar
  26. Davidson B, Baekelandt M, Shih IM (2007) MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Diagn Cytopathol 35(12):756–760PubMedCrossRefGoogle Scholar
  27. Davis MR et al (2015) Epithelioid trophoblastic tumor: a single institution case series at the New England Trophoblastic Disease Center. Gynecol Oncol 137(3):456–461PubMedCrossRefGoogle Scholar
  28. DeScipio C et al (2011) Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 35(10):1586–1591PubMedCrossRefGoogle Scholar
  29. Dotto J, Hui P (2008) Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. Int J Gynecol Pathol 27(4):562–567PubMedCrossRefGoogle Scholar
  30. Elston C (1995) Gestational trophoblastic disease. In: Fox H (ed) Haines and Taylor: textbook of obstetrical and gynecological pathology, 4th edn. Churchill Linvingstone, New York, pp 1597–1639Google Scholar
  31. Essel KG et al (2017) Salvage chemotherapy for gestational trophoblastic neoplasia: utility or futility? Gynecol Oncol 146(1):74–80PubMedCrossRefGoogle Scholar
  32. Fadare O et al (2006) Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol 19(1):75–82PubMedCrossRefGoogle Scholar
  33. Faes T et al (2012) Chorangiocarcinoma of the placenta: a case report and clinical review. Placenta 33(8):658–661PubMedCrossRefGoogle Scholar
  34. Fisher RA et al (2014) Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit. J Clin Pathol 67(11):980–984PubMedCrossRefGoogle Scholar
  35. Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156(2):361–381PubMedPubMedCentralCrossRefGoogle Scholar
  36. Garg R et al (2004) Have you ruled out a placental site nodule? Contempory OB/Gyn 49:18–20Google Scholar
  37. Garner EI et al (2007) Gestational trophoblastic disease. Clin Obstet Gynecol 50(1):112–122PubMedCrossRefGoogle Scholar
  38. Genest DR (2001) Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 20(4):315–322PubMedCrossRefGoogle Scholar
  39. Giordano G et al (2016) A case of placental site nodule associated with cervical high-grade squamous intraepithelial lesion. Eur J Gynaecol Oncol 37(2):259–261PubMedGoogle Scholar
  40. Golfier F et al (2007) First epidemiological data from the French Trophoblastic Disease Reference Center. Am J Obstet Gynecol 196(2):172 e1–172 e5CrossRefGoogle Scholar
  41. Golubovsky MD (2003) Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod 18(2):236–242PubMedCrossRefPubMedCentralGoogle Scholar
  42. Goto S et al (1993) Development of postmolar trophoblastic disease after partial molar pregnancy. Gynecol Oncol 48(2):165–170PubMedCrossRefGoogle Scholar
  43. Gupta M et al (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists. Am J Surg Pathol 36(12):1747–1760PubMedPubMedCentralCrossRefGoogle Scholar
  44. Gupta M et al (2017) Extrauterine placental site trophoblastic tumor involving the vagina. Int J Gynecol Pathol 36(3):294–299PubMedCrossRefGoogle Scholar
  45. Hamazaki S et al (1999) Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol 30:1321–1327PubMedCrossRefGoogle Scholar
  46. Hancock BW, Nazir K, Everard JE (2006) Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med 51(10):764–766PubMedGoogle Scholar
  47. Hando T, Ohno M, Kurose T (1998) Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet 60(Suppl 1):S71–S76PubMedCrossRefGoogle Scholar
  48. Harvey RA et al (2008) Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors. J Reprod Med 53(8):643–648PubMedGoogle Scholar
  49. Hassadia A et al (2005) Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol 99(3):603–607PubMedCrossRefGoogle Scholar
  50. Hernandez L et al (2003) Paternal and maternal genomes confer opposite effects on proliferation, cell-cycle length, senescence, and tumor formation. Proc Natl Acad Sci U S A 100(23):13344–13349PubMedPubMedCentralCrossRefGoogle Scholar
  51. Hoekstra AV, Keh P, Lurain JR (2004) Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. J Reprod Med 49(6):447–452PubMedPubMedCentralGoogle Scholar
  52. Horowitz NS, Goldstein DP, Berkowitz RS (2017) Placental site trophoblastic tumors and epithelioid trophoblastic tumors: biology, natural history, and treatment modalities. Gynecol Oncol 144(1):208–214PubMedCrossRefPubMedCentralGoogle Scholar
  53. How J et al (1995) Placental site trophoblastic tumor. Report of three cases and review of the literature. Int J Gynecol Cancer 5:241–249PubMedCrossRefPubMedCentralGoogle Scholar
  54. Hsieh TY et al (2008) Uterine choriocarcinoma accompanied by an extremely high human chorionic gonadotropin level and thyrotoxicosis. J Obstet Gynaecol Res 34(2):274–278PubMedCrossRefPubMedCentralGoogle Scholar
  55. Huang B et al (2015) Chorangiocarcinoma: a case report and clinical review. Int J Clin Exp Med 8(9):16798–16802PubMedPubMedCentralGoogle Scholar
  56. Huettner PC, Gersell DJ (1994) Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol 13(3):191–198PubMedCrossRefPubMedCentralGoogle Scholar
  57. Hui P et al (2000) Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Investig 80(6):965–972PubMedCrossRefPubMedCentralGoogle Scholar
  58. Hui P et al (2004) Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol 17(2):248–251PubMedCrossRefPubMedCentralGoogle Scholar
  59. Hui P et al (2017) Hydatidiform moles: genetic basis and precision diagnosis. Annu Rev Pathol 12:449–485PubMedCrossRefPubMedCentralGoogle Scholar
  60. Jacobs PA et al (1982) Complete and partial hydatidiform mole in Hawaii: cytogenetics, morphology and epidemiology. Br J Obstet Gynaecol 89(4):258–266PubMedCrossRefPubMedCentralGoogle Scholar
  61. Jacques SM et al (1997) Retained trophoblastic tissue in fallopian tubes: a consequence of unsuspected ectopic pregnancies. Int J Gynecol Pathol 16(3):219–224PubMedCrossRefPubMedCentralGoogle Scholar
  62. Jauniaux E (1999) Partial moles: from postnatal to prenatal diagnosis. Placenta 20(5–6):379–388PubMedCrossRefPubMedCentralGoogle Scholar
  63. Jiao L et al (2016) Intraplacental choriocarcinoma: systematic review and management guidance. Gynecol Oncol 141(3):624–631PubMedCrossRefPubMedCentralGoogle Scholar
  64. Jones WB et al (1993) Thoracotomy in the management of gestational choriocarcinoma. A clinicopathologic study. Cancer 72(7):2175–2181PubMedCrossRefPubMedCentralGoogle Scholar
  65. Kalhor N et al (2009) Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol 33:633–638PubMedCrossRefPubMedCentralGoogle Scholar
  66. Kaur B et al (2015) Atypical placental site nodule (APSN) and association with malignant gestational trophoblastic disease; a clinicopathologic study of 21 cases. Int J Gynecol Pathol 34(2):152–158PubMedCrossRefPubMedCentralGoogle Scholar
  67. Keep D et al (1996) Very early complete hydatidiform mole. Hum Pathol 27(7):708–713PubMedCrossRefPubMedCentralGoogle Scholar
  68. Kerkmeijer LG et al (2009) Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol 113(2 Pt 1):326–331PubMedCrossRefPubMedCentralGoogle Scholar
  69. Khong TY (2000) Chorangioma with trophoblastic proliferation. Virchows Arch 436(2):167–171PubMedCrossRefPubMedCentralGoogle Scholar
  70. Kim JH et al (1998) Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 71(1):108–112PubMedCrossRefPubMedCentralGoogle Scholar
  71. Kim SY, Chang AS, Ratts VS (2005) Radiographic and hysteroscopic findings of a placental site nodule. Fertil Steril 83(1):213–215PubMedCrossRefPubMedCentralGoogle Scholar
  72. Kim MJ et al (2006) Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods. Am J Surg Pathol 30(3):362–369PubMedCrossRefPubMedCentralGoogle Scholar
  73. Kurek C, Jaworski R, Lamaro V (2017) Extrauterine peritoneal placental site nodule. Pathology 49(5):560–561PubMedCrossRefPubMedCentralGoogle Scholar
  74. Kurman RJ (1991) The morphology, biology, and pathology of intermediate trophoblast: a look back to the present. Hum Pathol 22(9):847–855PubMedCrossRefPubMedCentralGoogle Scholar
  75. Kurman RJ, Shih IM (2014) Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol 33(4):339–347PubMedPubMedCentralCrossRefGoogle Scholar
  76. Kurman RJ, Scully RE, Norris HJ (1976) Trophoblastic pseudotumor of the uterus: an exaggerated form of “syncytial endometritis” simulating a malignant tumor. Cancer 38(3):1214–1226PubMedCrossRefPubMedCentralGoogle Scholar
  77. Kurman RJ et al (1984) Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol 3(1):101–121PubMedCrossRefPubMedCentralGoogle Scholar
  78. Lage JM et al (1992) A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 79(3):403–410PubMedCrossRefPubMedCentralGoogle Scholar
  79. Lee KR et al (2003) Tumors of the oary and peritoneum- surface epithelial-stromal tumors. In: Tavassoli FA, Devilee P (eds) Pathology and genetics: tumors of the breast and female genital organs. IARC Press, Lyon, pp 113–202Google Scholar
  80. Lee Y et al (2007) A unifying concept of trophoblastic differentiation and malignancy defined by biomarker expression. Hum Pathol 38(7):1003–1013PubMedCrossRefPubMedCentralGoogle Scholar
  81. Li HW, Tsao SW, Cheung AN (2002) Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 23(1):20–31PubMedCrossRefPubMedCentralGoogle Scholar
  82. Lipata F et al (2010) Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol 115(4):784–794PubMedCrossRefPubMedCentralGoogle Scholar
  83. Macdonald MC et al (2008) Diagnostic challenges in extrauterine epithelioid trophoblastic tumours: a report of two cases. Gynecol Oncol 108(2):452–454PubMedCrossRefPubMedCentralGoogle Scholar
  84. Machtinger R et al (2005) Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. Gynecol Oncol 96(1):56–61PubMedCrossRefPubMedCentralGoogle Scholar
  85. Mao TL et al (2006) Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor – an aid in differential diagnosis. Am J Surg Pathol 30(9):1105–1110PubMedCrossRefPubMedCentralGoogle Scholar
  86. Mao TL et al (2007) Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol 31:1726–1732PubMedCrossRefPubMedCentralGoogle Scholar
  87. Mao TL et al (2008) HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol 32(2):236–242PubMedCrossRefPubMedCentralGoogle Scholar
  88. Matsui H, Iizuka Y, Sekiya S (1996) Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet 53(1):63–64PubMedCrossRefPubMedCentralGoogle Scholar
  89. Mazur MT (1989) Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy. Cancer 63(7):1370–1377PubMedCrossRefPubMedCentralGoogle Scholar
  90. McCarthy WA et al (2017a) Atypical placental site nodule arising in a postcesarean section scar: case report and review of the literature. Int J Gynecol Pathol. PMID: 29140877,
  91. McCarthy WA et al (2017b) Comparison of p63 and p40 Immunohistochemical stains to distinguish epithelioid trophoblastic tumor from other trophoblastic lesions. Int J Gynecol PatholGoogle Scholar
  92. McConnell TG et al (2009a) Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 33:805–817PubMedCrossRefGoogle Scholar
  93. McConnell TG et al (2009b) Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 33(9):1409–1415PubMedCrossRefGoogle Scholar
  94. Menczer J et al (1999) Metastatic trophoblastic disease following partial hydatidiform mole: case report and literature review. Gynecol Oncol 74(2):304–307PubMedCrossRefGoogle Scholar
  95. Milingos D et al (2007) Placental site trophoblastic tumor with an ovarian metastasis. Int J Gynecol Cancer 17(4):925–927PubMedCrossRefGoogle Scholar
  96. Montes M et al (1996) Prevalence and significance of implantation site trophoblastic atypia in hydatidiform moles and spontaneous abortions. Am J Clin Pathol 105(4):411–416PubMedCrossRefGoogle Scholar
  97. Moore-Maxwell CA, Robboy SJ (2004) Placental site trophoblastic tumor arising from antecedent molar pregnancy. Gynecol Oncol 92(2):708–712PubMedCrossRefGoogle Scholar
  98. Morgan JM, Lurain JR (2008) Gestational trophoblastic neoplasia: an update. Curr Oncol Rep 10(6):497–504PubMedCrossRefGoogle Scholar
  99. Mosher R et al (1998) Complete hydatidiform mole. Comparison of clinicopathologic features, current and past. J Reprod Med 43(1):21–27PubMedPubMedCentralGoogle Scholar
  100. Murdoch S et al (2006) Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 38(3):300–302PubMedCrossRefGoogle Scholar
  101. Murphy KM et al (2012) Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol 31(1):73–79PubMedCrossRefGoogle Scholar
  102. Nagai Y et al (2007) Impact of p53 immunostaining in predicting advanced or recurrent placental site trophoblastic tumors: a study of 12 cases. Gynecol Oncol 106(3):446–452PubMedCrossRefGoogle Scholar
  103. Narita F et al (2003) Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer. Int J Gynecol Cancer 13(4):551–554PubMedCrossRefGoogle Scholar
  104. Nayar R et al (1996) Placental site nodule occurring in a fallopian tube. Hum Pathol 27(11):1243–1245PubMedCrossRefGoogle Scholar
  105. Newlands ES et al (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18(4):854–859PubMedCrossRefGoogle Scholar
  106. Ngan S, Seckl MJ (2007) Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 19(5):486–491PubMedCrossRefGoogle Scholar
  107. Niemann I, Hansen ES, Sunde L (2007) The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy. Gynecol Oncol 104(2):411–415PubMedCrossRefGoogle Scholar
  108. Nugent D et al (2006) Postpartum choriocarcinoma presentation, management and survival. J Reprod Med 51(10):819–824PubMedGoogle Scholar
  109. Numnum TM et al (2006) Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report. Gynecol Oncol 103(3):1141–1143PubMedCrossRefGoogle Scholar
  110. Oldt RJ 3rd, Kurman RJ, Shih IM (2002) Molecular genetic analysis of placental site trophoblastic tumors and epithelioid trophoblastic tumors confirms their trophoblastic origin. Am J Pathol 161(3):1033–1037PubMedPubMedCentralCrossRefGoogle Scholar
  111. Olsen JH et al (1999) Molar pregnancy and risk for cancer in women and their male partners. Am J Obstet Gynecol 181(3):630–634PubMedCrossRefPubMedCentralGoogle Scholar
  112. Palmer JR (1994) Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 39(3):155–162PubMedPubMedCentralGoogle Scholar
  113. Palmer JE et al (2008) Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med 53(7):465–475PubMedPubMedCentralGoogle Scholar
  114. Papadopoulos AJ et al (2002) Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med 47(6):460–464PubMedPubMedCentralGoogle Scholar
  115. Parry DA et al (2011) Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte. Am J Hum Genet 89(3):451–458PubMedPubMedCentralCrossRefGoogle Scholar
  116. Patten DK et al (2008) Gestational choriocarcinoma mimicking a uterine adenocarcinoma. J Clin Oncol 26(31):5126–5127PubMedCrossRefPubMedCentralGoogle Scholar
  117. Pfeffer PE et al (2007) Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol 8(8):744–746PubMedCrossRefPubMedCentralGoogle Scholar
  118. Piura B (2006) Placental site trophoblastic tumor – a challenging rare entity. Eur J Gynaecol Oncol 27(6):545–551PubMedPubMedCentralGoogle Scholar
  119. Piura B et al (2007) Placental site trophoblastic tumor: report of four cases and review of literature. Int J Gynecol Cancer 17(1):258–262PubMedCrossRefPubMedCentralGoogle Scholar
  120. Pluschke A et al (2014) Epithelioid trophoblastic tumour simulating a high grade carcinoma. Pathology 46(3):248–250PubMedCrossRefPubMedCentralGoogle Scholar
  121. Popiolek DA et al (2006) Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 37(11):1426–1434PubMedCrossRefPubMedCentralGoogle Scholar
  122. Redline RW, Hassold T, Zaragoza MV (1998) Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol 29(5):505–511PubMedCrossRefPubMedCentralGoogle Scholar
  123. Rinne K, Shahabi S, Cole L (1999) Following metastatic placental site trophoblastic tumor with urine β-core fragment. Gynecol Oncol 74:302–303PubMedCrossRefPubMedCentralGoogle Scholar
  124. Ronnett BM, DeScipio C, Murphy KM (2011) Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol 30(2):101–116PubMedCrossRefPubMedCentralGoogle Scholar
  125. Savage J et al (2017) Choriocarcinoma in women: analysis of a case series with genotyping. Am J Surg Pathol 41(12):1593–1606PubMedCrossRefPubMedCentralGoogle Scholar
  126. Seckl MJ et al (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356:36–39PubMedCrossRefPubMedCentralGoogle Scholar
  127. Sharkey AM et al (1999) Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod 60:355–364PubMedCrossRefPubMedCentralGoogle Scholar
  128. Shih IM (1999) The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189(1):4–11PubMedCrossRefPubMedCentralGoogle Scholar
  129. Shih IM (2007a) Gestational trophoblastic neoplasia – pathogenesis and potential therapeutic targets. Lancet Oncol 8(7):642–650PubMedCrossRefPubMedCentralGoogle Scholar
  130. Shih I-M (2007b) Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol 11(3):228–234PubMedCrossRefPubMedCentralGoogle Scholar
  131. Shih IM (2009) Gestational trophoblastic lesions. In: Oliva E, Nucci MR (eds) Gynecologic pathology. Churchill Livingstone Elsevier, New York, pp 645–665CrossRefGoogle Scholar
  132. Shih IM, Kuo KT (2008) Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol 173(4):911–914PubMedPubMedCentralCrossRefGoogle Scholar
  133. Shih IM, Kurman RJ (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Investig 75(3):377–388PubMedPubMedCentralGoogle Scholar
  134. Shih IM, Kurman RJ (1998a) Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol 29(1):27–33PubMedCrossRefPubMedCentralGoogle Scholar
  135. Shih I-M, Kurman RJ (1998b) Epithelioid trophoblastic tumor- a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22(11):1393–1403PubMedCrossRefPubMedCentralGoogle Scholar
  136. Shih IM, Kurman RJ (1999) Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol 18(2):144–150PubMedCrossRefPubMedCentralGoogle Scholar
  137. Shih IM, Kurman RJ (2001) The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 20(1):31–47PubMedCrossRefPubMedCentralGoogle Scholar
  138. Shih IM, Kurman RJ (2002) Molecular basis of gestational trophoblastic diseases. Curr Mol Med 2(1):1–12PubMedCrossRefPubMedCentralGoogle Scholar
  139. Shih IM, Kurman RJ (2004) p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol 28(9):1177–1183PubMedCrossRefPubMedCentralGoogle Scholar
  140. Shih IM et al (1997) Distribution of cells bearing the HNK-1 epitope in the human placenta. Placenta 18(8):667–674PubMedCrossRefPubMedCentralGoogle Scholar
  141. Shih IM, Seidman JD, Kurman RJ (1999) Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol 30(6):687–694PubMedCrossRefPubMedCentralGoogle Scholar
  142. Shih IM et al (2002) The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast. Placenta 23(10):706–715PubMedCrossRefPubMedCentralGoogle Scholar
  143. Silva EG et al (1993) Multiple nodules of intermediate trophoblast following hydatidiform moles. Int J Gynecol Pathol 12(4):324–332PubMedCrossRefPubMedCentralGoogle Scholar
  144. Singer G et al (2002) HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26(7):914–920PubMedCrossRefPubMedCentralGoogle Scholar
  145. Siu MKY et al (2008) Overexpression of Nanog in gestational trophoblastic diseases- effect on apoptosis, cell invasion and clinical outcome. Am J Pathol 173:1165PubMedPubMedCentralCrossRefGoogle Scholar
  146. Slim R, Mehio A (2007) The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet 71(1):25–34PubMedCrossRefPubMedCentralGoogle Scholar
  147. Soper JT (2006) Gestational trophoblastic disease. Obstet Gynecol 108(1):176–187PubMedCrossRefPubMedCentralGoogle Scholar
  148. Stichelbout M et al (2016) SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor. Hum Pathol 54:121–126PubMedCrossRefPubMedCentralGoogle Scholar
  149. Su YN et al (1999) Pregnancy with primary tubal placental site trophoblastic tumor – a case report and literature review. Gynecol Oncol 73(2):322–325PubMedCrossRefPubMedCentralGoogle Scholar
  150. Suzuki T et al (1993) Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol 82(4 Pt 1):629–634PubMedPubMedCentralGoogle Scholar
  151. Szulman AE, Surti U (1982) The clinicopathologic profile of the partial hydatidiform mole. Obstet Gynecol 59(5):597–602PubMedPubMedCentralGoogle Scholar
  152. Traboulsi W et al (2017) Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo. Clin Cancer Res 23:7130PubMedCrossRefPubMedCentralGoogle Scholar
  153. Tsai HW et al (2008) Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis. Histopathology 53(5):601–604PubMedGoogle Scholar
  154. Vang R et al (2012) Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis. Am J Surg Pathol 36(3):443–453PubMedPubMedCentralCrossRefGoogle Scholar
  155. Vencken PM, Ewing PC, Zweemer RP (2006) Epithelioid trophoblastic tumour: a case report and review of the literature. J Clin Pathol 59(12):1307–1308PubMedPubMedCentralCrossRefGoogle Scholar
  156. Veras E et al (2017) PD-L1 expression in human placentas and gestational trophoblastic diseases. Int J Gynecol Pathol 36(2):146–153PubMedPubMedCentralGoogle Scholar
  157. Wells M (2007) The pathology of gestational trophoblastic disease: recent advances. Pathology 39(1):88–96PubMedCrossRefGoogle Scholar
  158. Xu ML et al (2009) Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol 22(2):232–238PubMedCrossRefGoogle Scholar
  159. Xue WC et al (2002) Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer 94(8):2288–2294PubMedCrossRefGoogle Scholar
  160. Yap KL et al (2010) Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol 2010:364508PubMedPubMedCentralCrossRefGoogle Scholar
  161. Young RH, Scully RE (1984) Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol 27(1):248–258PubMedCrossRefGoogle Scholar
  162. Yuan CC, Wang PH, Ng HT (1999) High hCG level is a risk factor for predicting the occurrence of brain and/or liver metastases from gestational choriocarcinoma. Int J Gynaecol Obstet 65(1):67–69PubMedCrossRefGoogle Scholar
  163. Zalel Y, Dgani R (1997) Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases. Eur J Obstet Gynecol Reprod Biol 71(1):67–71PubMedCrossRefGoogle Scholar
  164. Zanetta G et al (1997) Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. Int J Gynecol Cancer 7:66–77PubMedCrossRefPubMedCentralGoogle Scholar
  165. Zhang H-J et al (2009) P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol 28:172–178PubMedCrossRefPubMedCentralGoogle Scholar
  166. Zhao S et al (2016a) Molecular genotyping of placental site and epithelioid trophoblastic tumours; female predominance. Gynecol Oncol 142(3):501–507PubMedCrossRefPubMedCentralGoogle Scholar
  167. Zhao J et al (2016b) Placental site trophoblastic tumor: a review of 108 cases and their implications for prognosis and treatment. Gynecol Oncol 142(1):102–108PubMedCrossRefPubMedCentralGoogle Scholar
  168. Zhou Y et al (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J Clin Invest 99:2139–2151PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Ie-Ming Shih
    • 1
    Email author
  • Brigitte M. Ronnett
    • 2
  • Michael Mazur
    • 3
  • Robert J. Kurman
    • 2
  1. 1.Department of Gynecology and ObstetricsJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of PathologyJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of PathologySUNY Upstate Medical UniversitySyracuseUSA

Personalised recommendations